{
    "code": "06017868",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06017868",
    "time": "2021-12-10 06:18:31",
    "許可證字號": "衛署醫器輸字第017868號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD4639",
    "有效日期": "116\/01\/03",
    "發證\/登錄日期": "96\/01\/03",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00601786802",
    "中文品名": "亞培設計師CA19-9 XR檢驗試劑組之校正液及品管液",
    "英文品名": "ABBOTT ARCHITECT CA19-9 XR calibrator and controls",
    "效能": "利用化學冷光微粒酵素免疫分析法(CMIA)定量測試人體血清或血漿中的1116-NS-19-9反應決定基(reactive determinants)。",
    "醫器規格": "ARCHITECT CA 19-9TMXR Reagent KitARCHITECT CA 19-9TMXR  Calibrators ARCHITECT CA 19-9TMXR Controls\r\n增加規格：2K91-23、2K91-28、2K91-38。\r\n註銷規格：2K91-20、2K91-25、2K91-30。\r\n標籤、仿單變更為：詳如中文仿單核定本（原96年1月16日仿單標籤核定本正本收回作廢）。以下空白\r\n註銷規格：2K91-23, 2K91-28, 2K91-38。以下空白",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "C免疫學及微生物學裝置",
    "醫器次類別一": "C6010腫瘤相關抗原免疫試驗系統",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "0932301100  美商亞培股份有限公司台灣分公司",
    "申請商地址": "台北市中山區民生東路三段49號5樓、6樓及51號6樓",
    "主製造廠": [
        {
            "": "UNITED STATES",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "06017868-110-07-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06017868&Seq=038&Type=9"
        },
        {
            "title": "06017868-110-07-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06017868&Seq=012&Type=8"
        }
    ]
}